Page last updated: 2024-10-31

metoclopramide and Lung Adenocarcinoma

metoclopramide has been researched along with Lung Adenocarcinoma in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Research Excerpts

ExcerptRelevanceReference
"Crizotinib is an orally active multi-target tyrosine kinase inhibitor which is the standard of care in patients with anaplastic lymphoma kinase translocated non-small-cell lung cancer."5.42When crizotinib-induced bradycardia becomes symptomatic: role of concomitant drugs. ( Aieta, M; Gallucci, G; Lombardi, L; Tartarone, A, 2015)
"Crizotinib is an orally active multi-target tyrosine kinase inhibitor which is the standard of care in patients with anaplastic lymphoma kinase translocated non-small-cell lung cancer."1.42When crizotinib-induced bradycardia becomes symptomatic: role of concomitant drugs. ( Aieta, M; Gallucci, G; Lombardi, L; Tartarone, A, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gallucci, G1
Tartarone, A1
Lombardi, L1
Aieta, M1

Other Studies

1 other study available for metoclopramide and Lung Adenocarcinoma

ArticleYear
When crizotinib-induced bradycardia becomes symptomatic: role of concomitant drugs.
    Expert review of anticancer therapy, 2015, Volume: 15, Issue:7

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Bradycardia;

2015